Additionally, BPC-157 is listed as a prohibited substance under the World Anti-Doping Code (World Anti-Doping Agency [WADA], 2024)
Storage and handling Proper peptide storage directly affects potency and safety
Benefits Exceptional weight loss: Patients with obesity (without diabetes) lost an average of 2224% of body weight at 48 weeks on 812 mg doses [3] [4]
Phase I data and clinical experience report no serious adverse events at doses up to 10 mg per injection
The "minimal initial benefit" group (approximately 5-10% of users) reported limited improvements during treatment making discontinuation effects irrelevant, typically explained by inadequate product quality with degraded or low-concentration GHK-Cu, inappropriate application technique reducing absorption, unrealistic expectations exceeding what any topical can achieve, severe underlying pathology requiring medical intervention beyond cosmetic peptides, or individual non-responsiveness to copper peptide treatment for genetic or physiological reasons
Shipping details: GCC shipments generally clear customs without issue